Biopsy and selective recall compared with immediate large loop excision in management of women with low grade abnormal cervical cytology referred for colposcopy: Multicentre randomised controlled trial

BMJ (Online)

Volumn 339, Issue 7716, 2009, Pages 330-

  Sharp, L ^a   Day, Nicholas ^b   Marteau, Theresa ^b   Parmar, Mahesh ^b   Patnick, Julietta ^b   Woodman, Ciaran ^b  

^a NATIONAL CANCER REGISTRY IRELAND   (Ireland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVERSE OUTCOME; ANXIETY; ARTICLE; CANCER INCIDENCE; CANCER SCREENING; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COLPOSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DYSKARYOSIS; EXCISION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PAIN; PATIENT REFERRAL; PRIORITY JOURNAL; PUNCH BIOPSY; RECALL; SELF REPORT; TREATMENT OUTCOME; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VAGINA BLEEDING; VAGINA DISCHARGE;

ADULT; BIOPSY, NEEDLE; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; COLPOSCOPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASS SCREENING; MIDDLE AGED; REFERRAL AND CONSULTATION; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 69449104032     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.b2548     Document Type: Article

References (47)

1. NHS Cervical Screening Programmes. Standards and quality in colposcopy. Sheffield: NHS Cervical Screening Programme, 1996. ( NHSCSP Publication No 2.)
2. NHS Cervical Screening Programmes. Colposcopy and programme management guidelines for the NHS cervical screening programme. Sheffield: NHS Cervical Screening Programmes, 2004. (NHSCSP Publication No 20.)
3. TOMBOLA Group. Refining the management of low-grade cervical abnormalities in the UK National Health Service, and defining the potential for HPV testing: a commentary on emerging evidence. J Low Genit Tract Dis 2006;10:26-38.
4. Walker EM, Dodgson J, Duncan ID. Does mild atypia on a cervical smear warrant further investigation? Lancet 1986;2:672-673
5. Flannelly G, Anderson D, Kitchener H, Mann E, Campbell M, Fisher P, et al. Management of women with mild and moderate cervical dyskaryosis. BMJ 1994;308:1399-1403 (Pubitemid 24159115)
6. Kitchener HC, Cruickshank ME, Farmery E. The 1993 British Society for Colposcopy and Cervical Pathology/National Coordinating Network United Kingdom colposcopy survey. Br J Obstet Gynaecol 1995;102:549-552
7. Van Hamont D, van Ham MA, Struik-van der Zanden PH, Keijser KG, Bulten J, Melchers WJ, et al. Long-term follow-up after large-loop excision of the transformation zone: evaluation of 22 years treatment of high-grade cervical intraepithelial neoplasia. Int J Gynecol Cancer 2006;16:615-619
8. Holschneider CH, Ghosh K, Montz FJ. See-and-treat in the management of high-grade squamous intraepithelial lesions of the cervix: a resource utilization analysis. Obstet Gynecol 1999;94:377-385 (Pubitemid 29393073)
9. Dunn TS, Burke M, Shwayder J. A "see and treat" management for high-grade squamous intraepithelial lesion pap smears. J Low Genit Tract Dis 2003;7:104-106
10. Scheungraber C, Kleekamp N, Schneider A. Management of low-grade squamous intraepithelial lesions of the uterine cervix. Br J Cancer 2004;90:975-978 (Pubitemid 38495814)
11. Cardenas-Turanzas M, Follen M, Benedet JL, Cantor SB. See-and-treat strategy for diagnosis and management of cervical squamous intraepithelial lesions. Lancet Oncol 2005;6:43-50. (Pubitemid 40089718)
12. Kyrgiou M, Koliopoulos G, Martin-Hirsch P, Arbyn M, Prendiville W, Paraskevaidis E. Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet 2006;367:489-498 (Pubitemid 43208905)
13. Jeronimo J, Schiffman M. Colposcopy at a crossroads. Am J Obstet Gynecol 2006;195:349-353
14. Buxton EJ, Luesley DM, Shafi MI, Rollason M. Colposcopically directed punch biopsy - a potentially misleading investigation. Br J Obstet Gynecol 1991;98:1273-1276
15. Allard JE, Rodriguez M, Rocca M, Parker MF. Biopsy site selection during colposcopy and distribution of cervical intraepithelial neoplasia. J Low Genit Tract Dis 2005;9:36-39 (Pubitemid 40116726)
16. Guido RS, Jeronimo J, Schiffman M, Solomon D, ALTS Group. The distribution of neoplasia arising on the cervix: results from the ALTS trial. Am J Obstet Gynecol 2005;193:1331-1337 (Pubitemid 41395100)
17. Byrom J, Douce G, Jones PW, Tucker H, Millinship J, Dhar K, et al. Should punch biopsies be used when high-grade disease is suspected at initial colposcopic assessment? A prospective study. Int J Gynecol Cancer 2006;16:253-256
18. Ostor AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Path 1993;12:186-192
19. Howe DT, Vincenti AC. Is large loop excision of the transformation zone (LLETZ) more accurate than colposcopically directed punch biopsy in the diagnosis of cervical intraepithelial neoplasia? Br J Obstet Gynaecol 1991;98:588-591
20. Bonardi R, Cecchini S, Grazzini G, Ciatto S. Loop electrosurgical excision procedure of the transformation zone and colposcopically directed punch biopsy in the diagnosis of cervical lesions. Obstet Gynecol 1992;80:1020-1022 (Pubitemid 23005852)
21. Massad LS, Halperin CJ, Bitterman P. Correlation between colposcopically directed biopsy and cervical loop excision. Gynecol Oncol 1996;6:400-403 (Pubitemid 26077625)
22. Denny LA, Soeters R, Dehaeck K, Bloch B. Does colposcopically directed punch biopsy reduce the incidence of negative LLETZ. Br J Obstet Gynecol 1995;102:545-548
23. Sadan O, Yarden H, Schejter E, Bilevsky E, Bachar R, Lurie S. Treatment of high-grade squamous intraepithelial lesions: a "see and treat" versus a three-step approach. Eur J Obstet Gynecol Reprod Biol 2007;131:73-75
24. Balasubramani L, Orbell S, Hagger M, Brown V, Tidy J. Do women with high-grade cervical intraepithelial neoplasia prefer a see and treat option in colposcopy? Br J Obstet Gynecol 2007;114:39-45.
25. Raffle AE, Gray JAM. Screening. Evidence and practice. Oxford: Oxford University Press, 2007.
26. TOMBOLA Group. Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study. BMJ 2009;339:b2549.
27. TOMBOLA Group. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial. BMJ 2009:389:b2546.
28. Cotton SC, Sharp L, Little J, Duncan I, Alexander L, Cruickshank ME, et al. Trial of management of borderline and other low-grade abnormal smears (TOMBOLA): trial design. Contemp Clin Trials 2006;27:449-471 (Pubitemid 44209242)
29. Chapter 4. The colposcope and techniques of colposcopy. In: Luesley DM, Shafi MI, Jordan JA, eds. Handbook of colposcopy. 2nd ed. London: Hodder Arnold, 2002.
30. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-370
31. National Cancer Institute (NCI). Treatment information for health professionals. Bethesda, MD: National Cancer Institute, 2004.
32. Etherington IJ, Luesley DM, Shafi MI, Dunn J, Hiller L, Jordan JA. Observer variability among colposcopists from the West Midlands region. Br J Obstet Gynaecol 1997;104:1380-1384 (Pubitemid 27517635)
33. Ferris DG, Litaker M, ALTS G. Interobserver agreement for colposcopy quality control using digitized colposcopic images during the ALTS trial. J Low Genit Tract Dis 2005;9:29-35. (Pubitemid 40116725)
34. Gage JC, Hanson VW, Abbey K, Dippery S, Gardner S, Kubota J, et al. Number of cervical biopsies and sensitivity of colposcopy. Obstet Gynecol 2006;108:264-272
35. Cox JT, Schiffman M, Solomon D, ASCUS-LSIL Triage Study (ALTS) Group. Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy. Am J Obstet Gynecol 2003;188:1406-1412 (Pubitemid 36741266)
36. TOMBOLA Group. After-effects reported by women following colposcopy, cervical biopsies and LLETZ: results from the TOMBOLA trial. Br J Obstet Gynaecol 2009; Jul 7 [Epub ahead of print].
37. Doyle M, Warwick A, Redman C, Hillier C, Chenoy R, O'Brien S. Does application of Monsel's solution after loop diathermy excision of the transformation zone reduce post operative discharge? Results of a prospective randomised controlled trial. Br J Obstet Gynaecol 1992;99:1023-1024
38. Woolley C, Philips Z, Whynes DK, Cotton SC, Gray NM, Sharp L, et al. United Kingdom cervical cancer screening and the costs of time and travel. Int J Technol Assess Health Care 2007;23:232-239 (Pubitemid 46646771)
39. Cervical cytology workload statistics. www.isdscotland.org/cervical- screening.
40. Cervical Screening Programme, England: 2004-2005. www.ic.nhs.uk/pubs/ cervicscrneng2005.
41. Castellsague X, Munoz N. Chapter 3: Cofactors in human papillomavirus carcinogenesis - role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst 2003;31:20-28
42. Parikh S, Brennan P, Boffetta P. Meta-analysis of social inequality and the risk of cervical cancer. Int J Cancer 2003;105:687-691 (Pubitemid 36687738)
43. Bosch FX, Iftner T. The aetiology of cervical cancer. Sheffield: NHS Cancer Screening Programmes, 2005.
44. Rana DN, Marshall J, Desai M, Kitchener HC, Perera DM, El Teraifi H, et al. Five-year follow-up of women with borderline and mildly dyskaryotic cervical smears. Cytopathol 2004;15:263-270 (Pubitemid 39389259)
45. Smith MC, Keech SE, Perryman K, Soutter WP. A long-term study of women with normal colposcopy after referral with low-grade cytological abnormalities. Br J Obstet Gynecol 2006;113:1321-1328 (Pubitemid 44581524)
46. Duncan ID, McKenzie CA, Wilson SM, Gurram S, Koppala S, Neillie LJ. Have we dismissed ablative treatment too soon in colposcopy practice? Br J Obstet Gynecol 2007;114:777-778
47. Paraskevaidis E, Kyrgiou M, Martin-Hirsch P. Have we dismissed ablative treatment too soon in colposcopy practice? Br J Obstet Gynecol 2007;114:3-4.